← Events

World Orphan Drug Congress USA will be returning on April 25-27, 2018 at the Gaylord National Harbor Hotel in Oxon Hill, Maryland.

Join 1000+ leaders in orphan drugs from 50 countries, covering all aspects of orphan drug development and rare disease research. 

Leading the discussion will be 250+ speakers including:

  • Sandy Macrae, President and Chief Executive Officer, Sangamo Therapeutics

  • Katherine High, President and Head, Research & Development, Spark Therapeutics

  • Andre Choulika, Chairman & Chief Executive Officer, Cellectis

  • Jacqueline Corrigan-Curay, Director, Office of Medical Policy, Center for Drug Evaluation and Research, FDA

  • Katrine Bosley, Chief Executive Officer, Editas Medicine

  • Jude Samulski, Vice President, Gene Therapy, Pfizer

  • Rodger Novak, Chief Executive Officer and Founder, CRISPR Therapeutics

  • Tim Miller, President and Chief Executive Officer, Abeona Therapeutics

  • Mark Rothera, President and Chief Executive Officer, Orchard Therapeutics

  • Hans Bishop, President & CEO, Juno Therapeutics

  • Kenneth Hobby, President, Cure SMA

  • Preston Campbell, President, Cystic Fibrosis Foundation

  • Brian Bronk, Head of External Innovation, Rare Diseases, Sanofi

  • Tanya Potashnik, Director, Policy and Economics Analysis Branch, Patented Medicine  Prices Review Board, Government of Canada

  • Kush Parmar, Managing Partner, 5AM Ventures

  • Jarbas Barbosa da Silva Jr, Director-President, ANVISA

  • Preston Campbell, President and Chief Executive Officer, Cystic Fibrosis Foundation

For the full conference agenda & list of speakers, download the brochure >>